Stage I Pancreatic Cancer AJCC v8 Clinical Trials

5 recruitingLast updated: June 18, 2026

There are 5 actively recruiting stage i pancreatic cancer ajcc v8 clinical trials across 1 country. Studies span Not Applicable, Phase 2. Top locations include Atlanta, Georgia, United States, Columbus, Ohio, United States, Portland, Oregon, United States. Updated daily from ClinicalTrials.gov.


Stage I Pancreatic Cancer AJCC v8 Trials at a Glance

5 actively recruiting trials for stage i pancreatic cancer ajcc v8 are listed on ClinicalTrialsFinder across 4 cities. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Atlanta, Columbus, and Portland. Lead sponsors running stage i pancreatic cancer ajcc v8 studies include Emory University, Mayo Clinic, and OHSU Knight Cancer Institute.

Browse stage i pancreatic cancer ajcc v8 trials by phase

Treatments under study

About Stage I Pancreatic Cancer AJCC v8 Clinical Trials

Looking for clinical trials for Stage I Pancreatic Cancer AJCC v8? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Stage I Pancreatic Cancer AJCC v8 trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Stage I Pancreatic Cancer AJCC v8 clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 15 of 5 trials

Recruiting
Not Applicable

A Tailored, Web-based Program (COMPASS) to Improve Exercise and Dietary Changes in Stage I-III Pancreatic Cancer Patients Receiving Neoadjuvant Chemotherapy

Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Stage I Pancreatic Cancer AJCC v8
OHSU Knight Cancer Institute30 enrolled1 locationNCT07651358
Recruiting
Phase 2

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Stage II Pancreatic Cancer AJCC v8Stage III Pancreatic Cancer AJCC v8Resectable Pancreatic Adenocarcinoma+2 more
Emory University36 enrolled1 locationNCT06423326
Recruiting
Not Applicable

A Brief Psychological Intervention to Improve Emotional Well-Being During Neoadjuvant Therapy for Pancreatic Cancer

Stage I Pancreatic Cancer AJCC v8Stage 0 Pancreatic Cancer AJCC v8Stage IIA Pancreatic Cancer AJCC v8+1 more
Ohio State University Comprehensive Cancer Center60 enrolled1 locationNCT07124611
Recruiting
Phase 2

Investigational Scan (68Ga-FAPI-46 PET/CT) for Imaging of Cancer-Associated Fibroblasts for Localized Pancreatic Ductal Adenocarcinoma

Stage I Pancreatic Cancer AJCC v8Localized Pancreatic AdenocarcinomaResectable Pancreatic Ductal Adenocarcinoma+2 more
Mayo Clinic130 enrolled1 locationNCT05518903
Recruiting

Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy

Borderline Resectable Pancreatic Ductal AdenocarcinomaStage I Pancreatic Cancer AJCC v8Resectable Pancreatic Ductal Adenocarcinoma
Emory University87 enrolled1 locationNCT06595160